Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Long-Read Sequencing Market Forecast: What Value Will The Market Reach By 2030?
The long-read sequencing market has witnessed substantial expansion in recent years. Projections indicate its growth from $1.15 billion in 2025 to $1.46 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 26.8%. Historically, this growth was primarily driven by factors such as the limitations inherent in short-read sequencing, the expansion of genomics research, advancements in nanopore sequencing technology, the rising demand for precise genome assembly, and an increase in funding across the life sciences sector.
The long-read sequencing market is set to experience significant expansion in the coming years, with its size projected to reach $3.74 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 26.5%. This growth during the forecast period is fueled by several factors, including the clinical integration of long-read sequencing, a reduction in sequencing costs, its combination with AI-based analysis, the broadening of oncology diagnostics, and the expansion of population genomics. Key trends anticipated during this period encompass the increasing adoption of long-read technologies, improved detection of structural variants, the rise of hybrid sequencing approaches, further development in rare disease genomics, and its growing application in complex genome assembly.
Get A Free Sample Report With In-Depth Market Insights:
Long-Read Sequencing Market Growth Momentum: What Factors Are Shaping Demand?
The growing occurrence of genetic conditions is anticipated to drive expansion in the long-read sequencing market in the future. Genetic diseases are health issues stemming from alterations or mutations in DNA, which can be passed down or emerge without clear cause, impacting health, growth, or physiological functions. The rise in these conditions is attributable to greater public awareness and progress in diagnostic tools, which facilitate earlier and more precise identification of previously undetected ailments. Long-read sequencing improves the management of genetic disorders by offering exceptionally accurate and thorough genomic information, rendering it highly effective for identifying intricate and uncommon diseases. It diminishes diagnostic ambiguities by identifying structural variations and complex mutations, thereby enhancing individualized treatment and clinical choices. For instance, in October 2024, data from the Cystic Fibrosis Trust, a national charity located in the UK, indicated that 11,148 individuals were living with cystic fibrosis (CF) in the UK in 2022, a number that rose to 11,318 in 2023. Consequently, the increasing incidence of genetic diseases is propelling the growth of the long-read sequencing market.
Long-Read Sequencing Market Segment Trends And Revenue Contributors
The long-read sequencing market covered in this report is segmented –
1) By Product And Service: Instruments Or Platforms, Consumables And Reagents, Services And Software
2) By Workflow: Pre-Sequencing, Sequencing, Data Analysis
3) By Technology Platform: Single Molecule Real-Time (SMRT) High-Fidelity (HiFi) Sequencing, Synthetic Long-Read Or Linked-Read, Hybrid And Other Emerging
4) By Application: Human Genomics And Rare-Disease Diagnostics, Oncology And Liquid Biopsy, Metagenomics And Microbiome, Transcriptomics, Agri Genomics And Plant Or Animal Breeding, Other Applications
5) By End User: Academic And Research Institutes, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End-Uses
Subsegments:
1) By Instruments Or Platforms: Single-Molecule Real-Time (SMRT) Sequencers, Nanopore Sequencers
2) By Consumables And Reagents: Library Preparation Kits, Sample Preparation Kits, Sequencing Kits
3) By Services And Software: Sequencing Services, Data Analysis Services, Bioinformatics Software
Long-Read Sequencing Market Trends Redefining Industry Growth
Leading companies within the long-read sequencing market are concentrating on creating advanced solutions, particularly HiFi reads, to improve the precision of sequencing, identify intricate genetic variations, and speed up genomic studies. High-fidelity (HiFi) reads denote lengthy DNA sequences produced by specific long-read sequencing methods, characterized by their extended read lengths and exceptionally low error rates, which facilitates precise identification of complex genetic and structural variations. An example is the launch in November 2024 by Pacific Biosciences of California Inc., a biotechnology firm based in the US, of its Vega system. This marks their initial benchtop long-read sequencing platform, intended to make genomic analysis quicker and more available. This system is a compact and cost-effective benchtop long-read sequencer, capable of providing highly accurate HiFi data with a 99.9% read accuracy. The Vega system supports rapid, adaptable sequencing for diverse applications, including RNA, targeted, and small genome sequencing, thereby extending sophisticated genomics capabilities to a wider range of laboratories. Furthermore, Vega streamlines operational processes through integrated computing and user-friendly operation, allowing researchers to efficiently uncover complex genetic information.
Long-Read Sequencing Market Key Players Shaping Industry Direction
Major companies operating in the long-read sequencing market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Revvity Inc., Bio-Rad Laboratories Inc., BGI Genomics Co. Ltd., Novogene Co. Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., New England Biolabs Inc., Roche Sequencing Solutions Inc., The Garvan Institute, Element Biosciences Inc., Eurofins Genomics, CD Genomics, BaseClear B.V, France Génomique, GrandOmics Biosciences Co. Ltd., Future Genomics Technologies B.V., MicrobesNG
View The Full Long-Read Sequencing Market Report:
Long-Read Sequencing Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the long-read sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the long-read sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.